Management, Body Systems, and Case Studies in COVID-19 (eBook, ePUB)

Redaktion: Rajendram AKC, BSc; R Martin RN, BSc; Patel BSc; Preedy BSc

• Format: ePub

Produktbeschreibung

COVID-19 Management in the Brain and Body describes the management of patients with the novel coronavirus in their varied symptoms. Detailing this multisystem disease and the variety of organs and tissues affected, this volume features chapters on neurological systems, including brain cancer, brain embolism, and meningoencephalitis. Several systems are addressed, including conditions affecting hematological, hepatobiliary, gastrointestinal, and cardiovascular systems. Telemedicine and are also discussed. This volume is relevant for all clinicians working to ensure the best outcomes and patient care of patients with COVID-19.

• Discusses the management of multisystem symptomatology, including the effects of COVID-19 on the neurological, respiratory, hematological, hepatobiliary, gastrointestinal, and cardiovascular systems
• Includes select guidelines for clinics providing care for COVID-19 patients
• Features individual chapter introductions, and a section on case studies to provide a comprehensive primer for each topic
• Contains chapters with key facts, dictionary of terms, summary points, applications to other areas pertinent to each chapter, and policies and procedures

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science & Techn.
• Seitenzahl: 600
• Erscheinungstermin: 15. Juni 2024
• Englisch
• ISBN-13: 9780443187049
• Artikelnr.: 72252004

Inhaltsangabe

Section A: Introductory chapters and setting the scene
1. Hand hygiene strategies
2. Approved vaccines for the COVID-19 pandemic: Linking in future
perspectives
3. Molecular methods for SARS-CoV-2 variant detection
Section B: Management
4. Systematic patient assessment for acute respiratory tract ailments
(SPARTA): A simple tool to improve outcomes from COVID-19
5. Point of care ultrasound for coronavirus disease 2019: The multiorgan
approach to COVID-19
6. COVID-19 in patients with inflammatory bowel diseases: Features and
guidelines
7. Management of COVID-19 and clinical nutrition
8. The management of head and neck cancer in COVID-19
9. The COVID-19 pandemic: Inventory management and allocation of personal
protective
equipment
10. Clinical management in the COVID-19 pandemic: Rheumatic disease
11. Managing migraines during the COVID-19 pandemic: An Italian experience
12. Managing acute ischemic stroke in the SARS-CoV-2 pandemic
13. Impact of the coronavirus disease 2019 pandemic on patients with
hypertension
14. Neurosurgical trauma management during COVID-19 restrictions
15. The COVID-19 pandemic and management of weight gain: Implications for
obesity
16. COVID-19 and the management of heart failure using telemedicine
Section C: Guidelines for different treatment clinics
17. Guidelines for breast imaging in the COVID-19 pandemic
18. Vaccine-induced (immune) thrombotic thrombocytopenia (VITT): Diagnosis,
guidelines,
and reporting
19. Lung cancer in the era of COVID-19
20. Multisystem inflammatory syndrome in children/pediatric inflammatory
multisystem
syndrome: Clinical guidelines
Section D: Impact on the respiratory system
21. Ground-glass nodules in the lungs of COVID-19 patients
22. Cardiothoracic imaging in patients affected by COVID-19
23. Cystic fibrosis and bronchial epithelial cells in SARS-CoV-2 infection
24. Biomechanics and mechanobiology of the lung parenchyma following
SARS-CoV-2 infection
25. Long noncoding RNA profiling in respiratory specimens from COVID-19
patients
26. COVID-19 and acute pulmonary embolism
27. The usefulness of the alveolar-arteriolar gradient during the COVID-19
pandemic
Section E: Effects on cardiovascular and hematological systems
28. Cardiac manifestations of COVID-19: An overview
29. Limb ischemia and COVID-19
30. Thrombosis and coagulopathy in COVID-19: A new narrative
31. COVID-19 myocarditis: Features of echocardiography
32. COVID-19 lockdown and impact on arrhythmias
33. Cardiometabolic disease and COVID-19: A new narrative
34. Postrecovery COVID-19 and interlinking diabetes and cardiovascular
events
35. COVID-19 patients and extracorporeal membrane oxygenation
36. Sars-CoV-2 infection in different hematological patients
Section F: Effects on body systems
37. Dermatological reactions associated with personal protective equipment
use during
the COVID-19 pandemic
38. Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccine
response
39. Coinfections with COVID-19: A focus on tuberculosis (TB)
40. Patients with autoimmune liver disease and the impact of Sars-COV-2
infection
41. COVID-19 severity and nonalcoholic fatty liver disease
42. Changes in obesity and diabetes severity during the COVID-19 pandemic
at Virginia
Commonwealth University health system
43. The diabetic patient and concomitant conditions rhinoorbital-cerebral
mucormycosis
and COVID-19
44. Tissue location of SARS-CoV-2 RNA: A focus on bone and implications for
skeletal health
45. Linking between gastrointestinal tract effects of COVID-19 and
tryptophan metabolism
46. Organ damage in SARS-CoV-2 infection in children: A focus on acute
kidney injury
47. Obesity, COVID-19 severity, and mortality
48. Upper and lower gastrointestinal symptoms and manifestations of
COVID-19
49. The COVID-19 survivors: Impact on skeletal muscle strength
Section G: Case studies with mini review
50. A case report: COVID-19 meningoencephalitis and intracranial hemorrhage
51. Case study: Oral mucosal lesions in patients with COVID-19
52. Case study: COVID-19 pneumonia presented with cavitary lesions
53. Case study: Optic neuritis in SARS-CoV-2 infection
Section H: Resources
54. Recommended resources relevant to the body systems involvement
and management of COVID-19